全文获取类型
收费全文 | 14823篇 |
免费 | 1134篇 |
国内免费 | 64篇 |
专业分类
耳鼻咽喉 | 211篇 |
儿科学 | 283篇 |
妇产科学 | 206篇 |
基础医学 | 2217篇 |
口腔科学 | 177篇 |
临床医学 | 1514篇 |
内科学 | 3578篇 |
皮肤病学 | 390篇 |
神经病学 | 1400篇 |
特种医学 | 651篇 |
外国民族医学 | 10篇 |
外科学 | 2397篇 |
综合类 | 44篇 |
一般理论 | 5篇 |
预防医学 | 642篇 |
眼科学 | 200篇 |
药学 | 960篇 |
中国医学 | 18篇 |
肿瘤学 | 1118篇 |
出版年
2023年 | 152篇 |
2022年 | 91篇 |
2021年 | 591篇 |
2020年 | 352篇 |
2019年 | 549篇 |
2018年 | 656篇 |
2017年 | 418篇 |
2016年 | 482篇 |
2015年 | 554篇 |
2014年 | 740篇 |
2013年 | 879篇 |
2012年 | 1314篇 |
2011年 | 1306篇 |
2010年 | 712篇 |
2009年 | 646篇 |
2008年 | 977篇 |
2007年 | 945篇 |
2006年 | 817篇 |
2005年 | 756篇 |
2004年 | 643篇 |
2003年 | 552篇 |
2002年 | 484篇 |
2001年 | 115篇 |
2000年 | 111篇 |
1999年 | 91篇 |
1998年 | 68篇 |
1997年 | 49篇 |
1996年 | 53篇 |
1995年 | 59篇 |
1994年 | 46篇 |
1993年 | 43篇 |
1992年 | 64篇 |
1991年 | 77篇 |
1990年 | 58篇 |
1989年 | 61篇 |
1988年 | 58篇 |
1987年 | 55篇 |
1986年 | 41篇 |
1985年 | 28篇 |
1984年 | 36篇 |
1983年 | 33篇 |
1982年 | 39篇 |
1981年 | 16篇 |
1980年 | 15篇 |
1979年 | 18篇 |
1978年 | 19篇 |
1974年 | 16篇 |
1973年 | 13篇 |
1972年 | 13篇 |
1968年 | 13篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
51.
52.
53.
François-Régis Duss Katia Jaton Peter Vollenweider Nicolas Troillet Gilbert Greub 《Clinical microbiology and infection》2021,27(6):910.e9-910.e13
Our institution has performed microbiological diagnosis of Tropheryma whipplei since 2001, initially with a PCR targeting 16S rRNA before the development of a quantitative PCR in 2012. Here we report the clinical characteristics of a cohort of patients suffering from Whipple disease (WD) and evaluate the impact of these molecular techniques. Patients with a positive PCR for T. whipplei between 2001 and 2016 were retrospectively collected from microbiological databases. Two infectious diseases specialists reviewed their medical records and classified them as definite WD, probable WD or carriage of T. whipplei without disease. A total of 1153 samples were tested for T. whipplei; 76 samples taken from 36 patients were positive. Fifteen were considered as presenting a definite WD, seven as a probable WD and 14 as carriers. Median age was 56.4 years (extremes, 6.6–76.1). Median time from symptoms to diagnosis was 3 years (2.5 months to 13.3 years). About 60% were immunosuppressed. The most frequent clinical presentations were joint pain (16/22), weight loss (15/22) and/or digestive tract disorder (15/22); 41% had neurological manifestations, 32% pulmonary involvement and 32% lymphadenopathies. Bacterial load in faeces or saliva were 88 425 copies/mL (IQR 6175-292 725) in definite and probable WD and 311 copies/mL (IQR 253–2090) in carriers, respectively. We observed a 90% PPV above 32 200 copies/mL in faeces. WD is a chronic multisystemic disease with frequent pulmonary involvement. Underlying immunodeficiency is commonly observed leading to more complex clinical presentation. Positive T. whipplei PCR in both stool and saliva has a high positive predictive value. Moreover, patients with WD present higher bacterial load in faeces with a threshold of >32 200 copies/mL predicting ongoing infection. 相似文献
54.
55.
56.
57.
58.
59.
Nicolas Penel Sylvie Bonvalot Marie-Cécile Le Deley Antoine Italiano Camille Tlemsani Diane Pannier Clémence Leguillette Jean-Emmanuel Kurtz Maud Toulmonde Julien Thery Daniel Orbach Pascale Dubray-Longeras Benjamin Verret François Bertucci Cécile Guillemet Lucie Laroche Armelle Dufresne Jean-Yves Blay Axel Le Cesne 《International journal of cancer. Journal international du cancer》2023,153(2):407-416
The aim of this study is to evaluate the prevalence, determinants and prognostic value of pain at diagnosis in patients with desmoid-type fibromatosis (DF). We selected patients from the ALTITUDES cohort (NCT02867033), managed by surgery, active surveillance or systemic treatments, with pain assessment at diagnosis. Patients were invited to fill QLQ-C30 questionnaire and Hospital Anxiety Depression Scale. Determinants were identified using logistic models. Prognostic value on event-free survival (EFS) was evaluated using the Cox model. Overall, 382 patients were included in the current study (median age: 40.2 years; 117 men). The prevalence of pain was 36%, without significant difference according to first-line treatment (P = .18). In the multivariate analysis, pain was significantly associated with tumor size >50 mm (P = .013) and tumor site (P < .001); pain was more frequent in the neck and shoulder locations (odds ratio: 3.05 [1.27-7.29]). Pain at baseline was significantly associated with poor quality of life (P < .001), depression (P = .02), lower performance status (P = .03) and functional impairment (P = .001); we also observed a nonsignificant association with anxiety (P = .10). In the univariate analysis, baseline pain was associated with poor EFS; the 3-year EFS was 54% in patients with pain compared to 72% in those without pain. After adjustment for sex, age, size and line of treatment, pain was still associated with poor EFS (hazard ratio: 1.82 [1.23-2.68], P = .003). One third of recently diagnosed patients with DF experienced pain, especially those with larger tumors and neck/shoulder locations. Pain was associated with unfavorable EFS after adjustment for the confounders. 相似文献
60.
Alexis Viel Jérôme Henri Salim Bouchène Julian Laroche Jean-Guy Rolland Jacqueline Manceau Michel Laurentie William Couet Nicolas Grégoire 《Pharmaceutical research》2018,35(5):92